World's Best Scientists 2026 revealed!
Infection and Chemotherapy
H-index 12

Infection and Chemotherapy

2093-2340

Published by: Korean Society of Infectious Diseases

https://www.icjournal.org/#

Ranking & Metrics

Discipline name Position Best Scientists Publications D-Index
Microbiology 203 10 32 10

Additional Metrics

Number of Best Scientists*: 21
Documents by Best Scientists*: 49
Top 100 Ranked Scientists*: 0
SCIMAGO H-index: 40
SCIMAGO SJR: 0.685
Impact Factor: 2.9

Overview

Top Research Topics at Infection and Chemotherapy?

The topics of Internal medicine, Microbiology, Antibiotics, Virology and Intensive care medicine are the focal point of discussions in Infection and Chemotherapy. The research on Internal medicine tackled can also make contributions to studies in the areas of Gastroenterology, Surgery and Bacteremia. Specifically, studies on Antibiotic resistance are prevalent in the Microbiology works discussed.

Issues in Antibiotics were discussed, taking into consideration concepts from other disciplines like Pharmacotherapy and Drug resistance. The journal connects the study in Virology with the closely related area of Immunology.

  • Internal medicine (22.73%)
  • Microbiology (16.17%)
  • Antibiotics (13.21%)

What are the most cited papers published in the journal?

  • Cytomegalovirus infections in solid organ transplantation: a review. (166 citations)
  • Age Related Morbidity and Mortality among Patients with COVID-19 (147 citations)
  • Epidemiology and Characteristics of Metallo-β-Lactamase-Producing Pseudomonas aeruginosa. (136 citations)

Research areas of the most cited articles at Infection and Chemotherapy:

The main points discussed in the most cited articles deal with Intensive care medicine, Antibiotics, Microbiology, Epidemiology and Internal medicine. The most cited papers hold forums on Intensive care medicine that merge themes from other disciplines such as Guideline, Pandemic, Drug resistance and Etiology. While the journal articles focused on Internal medicine, they were also able to explore topics like Bacteremia and Gastroenterology.

What topics the last edition of the journal is best known for?

  • Internal medicine
  • Disease
  • Antibiotics

The previous edition focused in particular on these issues:

The journal facilitates discussions on Internal medicine, Coronavirus disease 2019 (COVID-19), Odds ratio, Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) and Antibiotics. It holds forums on Internal medicine that merges themes from other disciplines such as Antibiotic resistance and Viral load. Issues in Coronavirus disease 2019 (COVID-19) were discussed, taking into consideration concepts from other disciplines like Evidence based healthcare, Scopus, Pneumonia and Vaccination.

Some problems in Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) that were presented in Infection and Chemotherapy overlapped with concepts under Clinical trial, Intensive care medicine, Prospective survey, Severe disease and 2019-20 coronavirus outbreak. Infection and Chemotherapy investigates Antibiotics research which frequently intersects with Etiology. Microbiology research presented in it encompasses a variety of subjects, including Septic shock and Klebsiella pneumoniae.

The most cited articles from the last journal are:

  • Revised Korean society of infectious diseases/national evidence-based healthcarea collaborating agency guidelines on the treatment of patients with COVID-19 (5 citations)
  • COVID-19 vaccination for people with comorbidities (5 citations)
  • Nosocomial Outbreak of COVID-19 in a Hematologic Ward. (2 citations)

Papers citation over time

A key indicator for each journal is its effectiveness in reaching other researchers with the papers published at that venue.

The chart below presents the interquartile range (first quartile 25%, median 50% and third quartile 75%) of the number of citations of articles over time.

The top authors publishing in Infection and Chemotherapy (based on the number of publications) are:

  • Dong-Gun Lee (50 papers) absent at the last edition,
  • Jun Yong Choi (48 papers) absent at the last edition,
  • Hee Jin Cheong (44 papers) published 2 papers at the last edition the same number as at the previous edition,
  • June Myung Kim (42 papers) absent at the last edition,
  • Woo Joo Kim (40 papers) absent at the last edition.

The overall trend for top authors publishing in this journal is outlined below. The chart shows the number of publications at each edition of the journal for top authors.

Only papers with recognized affiliations are considered

The top affiliations publishing in Infection and Chemotherapy (based on the number of publications) are:

  • Catholic University of Korea (121 papers) published 3 papers at the last edition, 7 less than at the previous edition,
  • Korea University (103 papers) published 8 papers at the last edition, 1 more than at the previous edition,
  • Yonsei University (97 papers) published 5 papers at the last edition, 6 less than at the previous edition,
  • University of Ulsan (66 papers) published 7 papers at the last edition, 4 more than at the previous edition,
  • New Generation University College (61 papers) published 3 papers at the last edition, 4 less than at the previous edition.

The overall trend for top affiliations publishing in this journal is outlined below. The chart shows the number of publications at each edition of the journal for top affiliations.

Publication chance based on affiliation

The publication chance index shows the ratio of articles published by the best research institutions in the journal edition to all articles published within that journal. The best research institutions were selected based on the largest number of articles published during all editions of the journal.

The chart below presents the percentage ratio of articles from top institutions (based on their ranking of total papers).Top affiliations were grouped by their rank into the following tiers: top 1-10, top 11-20, top 21-50, and top 51+. Only articles with a recognized affiliation are considered.

During the most recent 2021 edition, 6.25% of publications had an unrecognized affiliation. Out of the publications with recognized affiliations, 35.00% were posted by at least one author from the top 10 institutions publishing in the journal. Another 6.67% included authors affiliated with research institutions from the top 11-20 affiliations. Institutions from the 21-50 range included 8.33% of all publications and 50.00% were from other institutions.

Returning Authors Index

A very common phenomenon observed among researchers publishing scientific articles is the intentional selection of journals they have already attended in the past. In particular, it is worth analyzing the case when the authors participate in the same journal from year to year.

The Returning Authors Index presented below illustrates the ratio of authors who participated in both a given as well as the previous edition of the journal in relation to all participants in a given year.

Returning Institution Index

The graph below shows the Returning Institution Index, illustrating the ratio of institutions that participated in both a given and the previous edition of the conference in relation to all affiliations present in a given year.

The experience to innovation index

Our experience to innovation index was created to show a cross-section of the experience level of authors publishing in a journal. The index includes the authors publishing at the last edition of a journal, grouped by total number of publications throughout their academic career (P) and the total number of citations of these publications ever received (C).

The group intervals were selected empirically to best show the diversity of the authors' experiences, their labels were selected as a convenience, not as judgment. The authors were divided into the following groups:

  • Novice - P < 5 or C < 25 (the number of publications less than 5 or the number of citations less than 25),
  • Competent - P < 10 or C < 100 (the number of publications less than 10 or the number of citations less than 100),
  • Experienced - P < 25 or C < 625 (the number of publications less than 25 or the number of citations less than 625),
  • Master - P < 50 or C < 2500 (the number of publications less than 50 or the number of citations less than 2500),
  • Star - P ≥ 50 and C ≥ 2500 (both the number of publications greater than 50 and the number of citations greater than 2500).

The chart below illustrates experience levels of first authors in cases of publications with multiple authors.

Top Publications

  • Fluvoxamine Treatment of Patients with Symptomatic COVID-19 in a Community Treatment Center: A Preliminary Result of Randomized Controlled Trial

    (2022)
    54 Citations
  • Interim Guidelines on Antiviral Therapy for COVID-19.

    Sun Bean Kim;Kyungmin Huh;Jung Yeon Heo;Eun Jeong Joo

    (2020)
    37 Citations
  • Emergent Strategies for the Next Phase of COVID-19.

    Kyungmin Huh;Hyoung Shik Shin;Kyong Ran Peck

    (2020)
    24 Citations
  • Revised Korean society of infectious diseases/national evidence-based healthcarea collaborating agency guidelines on the treatment of patients with COVID-19

    Sun Bean Kim;Seungeun Ryoo;Kyungmin Huh;Eun Jeong Joo

    (2021)
    24 Citations
  • Evolution of Antimicrobial Resistance Levels of ESKAPE Microorganisms in a Peruvian IV-Level Hospital

    Wilfredo Flores-Paredes;Nestor Luque;Roger Albornoz;Nayade Rojas

    (2021)
    18 Citations
  • Clinical Features and Outcomes of Invasive Fusariosis: A Case Series in a Single Center with Literature Review.

    Ji Yeon Kim;Cheol In Kang;Ji Hye Lee;Woo Joo Lee

    (2021)
    17 Citations
  • Severe Thrombocytopenia in a Patient with COVID-19.

    Eliel Nham;Jae Hoon Ko;Byeong Ho Jeong;Kyungmin Huh

    (2020)
    17 Citations
  • High Prevalence of blaCTX-M in Fecal Commensal Escherichia coli from Healthy Children

    (2021)
    14 Citations
  • Characteristics and Clinical Outcomes of Extended-Spectrum beta-lactamase-producing Klebsiella pneumoniae Bacteremia in Cancer Patients.

    Eliel Nham;Kyungmin Huh;Sun Young Cho;Doo Ryeon Chung

    (2020)
    12 Citations
  • Historical and Clinical Perspective of Vibrio vulnificus Infections in Korea

    Seung Ji Kang;Sook In Jung;Kyong Ran Peck

    (2020)
    11 Citations

Best Scientists Contributing to This Journal